Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Eur J Immunol. 2012 Oct;42(10):2754-9. doi: 10.1002/eji.201141653. Epub 2012 Jul 19.
The PI-3 kinase (PI3K) pathway is critical for T-cell development and activation. Several negative regulators of this pathway have already been described and characterized: the lipid phosphatases SHIP, inositol polyphosphate-4-phosphatase, type II (INPP4B), and phosphatase and tensin homolog (PTEN), the latter of which are tumor suppressors. PIK3IP1 (PI3K interacting protein 1) is a recently described transmembrane protein that has the ability to bind the catalytic protein p110 and prevent its activation by the p85 family adaptor proteins. Thus far, nothing is known about the possible role of PIK3IP1 in the regulation of lymphocyte development or activation. Here, we show for the first time that PIK3IP1 is expressed in T cells. Ectopic expression of PIK3IP1 in Jurkat or D10 T-cell lines inhibited activation of an NFAT/AP-1 transcriptional reporter. Conversely, siRNA-mediated silencing of PIK3IP1 in the same cell lines modestly augmented Akt phosphorylation, T-cell activation, and production of IL-2. These results suggest that the novel PI3K regulator PIK3IP1 plays an inhibitory role in T-cell activation.
PI3 激酶(PI3K)通路对于 T 细胞的发育和激活至关重要。已经描述并表征了该通路的几种负调控因子:脂质磷酸酶 SHIP、肌醇多磷酸-4-磷酸酶 II(INPP4B)和磷酸酶和张力蛋白同源物(PTEN),后两者是肿瘤抑制因子。PIK3IP1(PI3K 相互作用蛋白 1)是一种最近描述的跨膜蛋白,具有与催化蛋白 p110 结合并防止其被 p85 家族衔接蛋白激活的能力。迄今为止,尚不清楚 PIK3IP1 在调节淋巴细胞发育或激活中的可能作用。在这里,我们首次表明 PIK3IP1 在 T 细胞中表达。PIK3IP1 在 Jurkat 或 D10 T 细胞系中的异位表达抑制了 NFAT/AP-1 转录报告基因的激活。相反,在相同的细胞系中,通过 siRNA 介导的 PIK3IP1 沉默适度增强了 Akt 磷酸化、T 细胞激活和 IL-2 的产生。这些结果表明,新型 PI3K 调节剂 PIK3IP1 在 T 细胞激活中发挥抑制作用。